Azilsartan Medoxomil Medications

Azilsartan Medoxomil is a prodrug of an angiotensin receptor blocker used to treat high blood pressure.

Edarbyclor

Azilsartan Medoxomil / Chlorthalidone

$1.35 per pill

40/12.5mg

Select pack

About Azilsartan Medoxomil

Azilsartan Medoxomil is a potent angiotensin II receptor blocker (ARB) approved for the treatment of hypertension. It belongs to the sartans class, which antagonizes the binding of angiotensin II to the AT₁ receptor, thereby relaxing vascular smooth muscle and lowering blood pressure. The compound is marketed worldwide under the brand name Edarbi and is also available as a generic tablet. Clinical trials have shown reliable reductions in systolic and diastolic pressures, often superior to older ARBs. While its primary indication is essential hypertension, some investigators have explored its use in chronic kidney disease and heart-failure cohorts, although these applications remain off-label. Patients in Australia may obtain azilsartan medoxomil through our online pharmacy, where both brand-name and generic options are stocked, provided a valid prescription is supplied.

What is Azilsartan Medoxomil?

Azilsartan medoxomil is a pro-drug that is hydrolysed after ingestion to the active moiety azilsartan. It is classified as an angiotensin II receptor blocker, a subclass of antihypertensive agents that selectively block the AT₁ receptor. The U.S. Food and Drug Administration approved azilsartan medoxomil in 2011 for adults with hypertension, and the European Medicines Agency granted a similar indication shortly thereafter. The Therapeutic Goods Administration of Australia has not listed azilsartan medoxomil on the Australian Register of Therapeutic Goods, so it is accessed privately rather than through the PBS.

At the molecular level, azilsartan binds with high affinity to the AT₁ receptor on vascular smooth muscle, adrenal cortex, and renal tubules. By preventing angiotensin II-mediated vasoconstriction, aldosterone secretion, and sodium reabsorption, the drug produces a sustained reduction in systemic vascular resistance and promotes natriuresis. Both the branded product Edarbi and generic tablets are available for purchase from our pharmacy service, offering a cost-effective alternative to older ARBs.

How Azilsartan Medoxomil Works

Mechanism of Action

Azilsartan medoxomil is absorbed in the gastrointestinal tract and rapidly converted by esterases to azilsartan. The active compound occupies the AT₁ receptor site, blocking the endogenous ligand angiotensin II. This inhibition halts the downstream signaling cascade that normally triggers phospholipase C activation, intracellular calcium rise, and smooth-muscle contraction. Because the AT₁ receptor also mediates aldosterone release, azilsartan reduces sodium and water retention, further contributing to its antihypertensive effect.

Therapeutic Effects

The blockade of AT₁ receptors results in vasodilation of arterioles and veins, lowering both systolic and diastolic blood pressure. In addition, reduced aldosterone levels diminish extracellular fluid volume, which helps maintain a stable blood pressure over 24 hours. Clinical studies have reported mean reductions of 10-15 mm Hg in systolic pressure after eight weeks of therapy, outperforming several earlier ARBs in head-to-head trials.

Onset and Duration

Peak plasma concentrations of azilsartan are reached within 1.5-3 hours after a single dose, and the antihypertensive effect typically becomes noticeable within 4 days of daily administration. The drug’s half-life ranges from 11 to 13 hours, supporting once-daily dosing. Steady-state plasma levels are achieved after approximately 5 days, at which point blood-pressure control stabilizes for the duration of therapy.

Approved Uses and Applications

Approved Indications

Essential hypertension - The primary indication approved by the FDA and EMA for adult patients. Clinical guidelines list azilsartan medoxomil as a first-line option when monotherapy or combination therapy is required.

Off-Label Uses

Chronic kidney disease with proteinuria - Small-scale studies suggest that ARBs, including azilsartan, may reduce albumin excretion, although this use lacks formal regulatory endorsement.
Heart failure with reduced ejection fraction - Early phase-II trials have examined azilsartan as part of a multi-drug regimen; the data are insufficient for official approval.

All off-label applications remain investigational and should be considered only under specialist supervision.

Clinical Efficacy

A pivotal double-blind trial published in The New England Journal of Medicine demonstrated that azilsartan medoxomil achieved a mean systolic blood-pressure reduction of 12.5 mm Hg compared with 10.2 mm Hg for telmisartan after eight weeks (p < .01). Another multicentre study in Lancet reported that 68 % of participants reached target blood pressure (<140/90 mm Hg) with azilsartan, versus 55 % with valsartan. These results underline the drug’s robust efficacy profile across diverse patient populations.

Buying Azilsartan Medoxomil from Our Online Pharmacy

Why Choose Our Service

Access to newer antihypertensives can be limited in Australia, especially when they are not listed on the PBS. Through our platform, patients receive a discreet, secure channel for obtaining azilsartan medoxomil without the usual pharmacy bottlenecks. Every order is processed by licensed pharmacists who verify prescription legitimacy, ensuring both safety and compliance.

Brand Names and Generic Options

Edarbi (Merck) - the original branded formulation, often preferred for its proven track record.
Generic azilsartan medoxomil - chemically identical, typically 30-45 % cheaper than the brand.
Combination tablets (azilsartan + hydrochlorothiazide) - available for patients who need an added diuretic component.

Our online pharmacy stocks these options, allowing you to select the most suitable formulation for your treatment plan.

Quality & Safety

We partner with internationally accredited pharmacies that operate under strict regulatory frameworks, including compliance with WHO Good Manufacturing Practices. Every batch undergoes third-party verification for potency, purity, and packaging integrity.

Pricing & Access

Generic azilsartan medoxomil tablets start at AU$.85 per 40 mg tablet, while the brand-name Edarbi is priced around AU$2.10 per tablet. In addition, we offer a Lifetime 10 % discount on all reorders, making long-term therapy more affordable.

Discreet Delivery

Orders ship via express (≈ 7 days) or standard (≈ 3 weeks) services. Packages are unmarked, sealed in tamper-evident envelopes, and include a tracking number for real-time monitoring.

Dosing, Formulations & Administration

Available Formulations

Azilsartan medoxomil is supplied as oral tablets in the following strengths: 20 mg, 40 mg, and 80 mg. Fixed-dose combinations with hydrochlorothiazide are offered as 40 mg/12.5 mg and 80 mg/25 mg tablets.

Typical Dosing Ranges

For adults with hypertension, clinicians often start treatment at 40 mg once daily. If blood-pressure goals are not achieved after two weeks, the dose may be titrated to 80 mg once daily. Combination products are generally initiated at the lower azilsartan component (40 mg) plus the diuretic dose, then adjusted based on response and tolerability.

Administration Guidelines

The tablet should be swallowed whole with a glass of water. Food does not significantly affect absorption, so dosing time can be chosen for convenience. For patients on the combination product, taking the medication in the morning may reduce nocturnal diuresis.

A qualified healthcare professional must determine the exact dose based on individual factors such as renal function, concomitant medications, and overall cardiovascular risk.

Safety Profile & Considerations

Common Side Effects

Dizziness - reported in ≈ 12 % of participants.
Headache - observed in ≈ 9 % of users.
Fatigue - noted in ≈ 8 % of trial subjects.
Hyperkalemia - laboratory-detected elevation of serum potassium in ≈ 5 % of patients.
Elevated serum creatinine - occurred in ≈ 4 % of individuals, usually transient.

These events are generally mild to moderate and resolve without discontinuation.

Serious Adverse Events

Angio-edema - rare but potentially life-threatening; immediate medical attention required.
Severe hypotension - may present with syncope, especially in patients on diuretics or with volume depletion.
Renal impairment - abrupt rises in creatinine >30 % from baseline warrant evaluation.

Contraindications

Known hypersensitivity to azilsartan, its salts, or any component of the formulation.
Pregnancy - ARBs are classified as Category D; they can cause fetal renal dysfunction and should be avoided.
Concurrent use of ACE inhibitors - combined therapy increases the risk of angio-edema and hyperkalemia.

Drug Interactions

Potassium-sparing diuretics (e.g., spironolactone) and potassium supplements - raise serum potassium levels.
Non-steroidal anti-inflammatory drugs (NSAIDs) - may diminish antihypertensive efficacy and increase renal risk.
Cytochrome P450 inhibitors - azilsartan is minimally metabolised by CYP enzymes, but strong inhibitors (e.g., ketoconazole) can modestly raise plasma concentrations.
Other renin-angiotensin system blockers - concurrent use is contraindicated due to additive hypotensive and renal effects.

Special Populations

Pregnancy & breastfeeding - contraindicated; alternative antihypertensives should be selected.
Elderly - start at the low end of the dosing range; monitor renal function and electrolytes closely.
Renal impairment - dose reduction to 20 mg daily is recommended when eGFR < 30 mL/min/1.73 m².
Hepatic impairment - no specific dose adjustment required, but routine liver-function monitoring is prudent.

Frequently Asked Questions

How does azilsartan medoxomil differ from losartan? Azilsartan exhibits higher AT₁-receptor binding affinity and a longer half-life, which translates into greater blood-pressure reductions in comparative trials.
How long before azilsartan medoxomil produces noticeable effects for hypertension? Most patients report a reduction in systolic pressure within 4-7 days; full steady-state effect is typically reached after about 5 days of daily dosing.
What should I do if I experience dizziness after starting azilsartan medoxomil? Dizziness is a common early-treatment sensation. Sit or lie down until it resolves, avoid sudden posture changes, and discuss persistent symptoms with your clinician.
Can azilsartan medoxomil be taken with food? Food does not significantly alter drug absorption, so the tablet can be taken with or without meals according to personal preference.
Is it safe to combine azilsartan medoxomil with a potassium supplement? Concurrent potassium supplementation can raise serum potassium to unsafe levels; a healthcare provider should evaluate the need for supplementation.
What are the risks of using azilsartan medoxomil during pregnancy? ARBs can cause fetal kidney injury, oligohydramnios, and skull hypoplasia. The medication should be discontinued and an alternative antihypertensive chosen as soon as pregnancy is confirmed.
Will azilsartan medoxomil interact with my over-the-counter ibuprofen? NSAIDs may blunt the blood-pressure-lowering effect and increase renal stress, especially in patients with pre-existing kidney disease. Discuss regular ibuprofen use with your prescriber.
Do I need to monitor my blood tests while on azilsartan medoxomil? Baseline and periodic monitoring of serum potassium and creatinine is recommended, particularly in patients with renal insufficiency or those taking diuretics.
What information should I provide my doctor when discussing azilsartan medoxomil?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of kidney or liver disease, electrolyte abnormalities, or prior angio-edema.
- Current blood-pressure readings and any recent changes in symptoms.
- Pregnancy status or plans for pregnancy.

Disclaimer

The information provided about azilsartan medoxomil is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing azilsartan medoxomil for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing azilsartan medoxomil.